nav-left cat-right
cat-right

Seegene Receives FDA Clearance for its Herpes Simp...

Gaithersburg, Maryland and SEOUL, Korea, February 17, 2015 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for its TOCE™-based herpes simplex virus (HSV) types 1 and 2 assay. This is the first product that Seegene has taken through the FDA, and it opens the way for Seegene’s other...

Seegene Receives US Patent for TOCE Technology

Gaithersburg, Maryland and SEOUL, Korea, November 19, 2014 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that it has been issued a United States Patent, No. 8,809,239, for its tagging oligonucleotide capture and extension (TOCE™) technology, which enables highly multiplexed target amplification and detection in a single tube. TOCE™ technology is now IP protected in...

Researchers create protein with potential for weig...

It sounds like a magic bullet: Administer a protein, watch the subject lose weight. But that’s exactly what University of Florida scientists found when they discovered a new way to deliver a protein that helps develop cells that convert fat into energy. The study builds upon on a discovery by Bruce Spiegelman, a cell biologist at the Boston-based Dana-Farber Cancer Institute, who found that human muscles release a hormone...

New Protein Finding Gives Hope to Infertility Pati...

Answering the question of “how do babies come in this world” is not easy at any age. You may laugh now, but as children we all heard the stories about some birds and some bees, some storks or other similar versions, while as adults, we are probably telling our children the same tales, so they can find out later, in an academical environment, the truth about conception and birth. But science went even further in trying to...

Sony teams with Illumina working on Japanese genom...

Sony has struggled financially in recent years, with its shrinking share of the TV market and a sector-wide slump in PC sales dragging the company down. With the electronics business floundering, management is looking to other sectors to prop up the business and thinks it has found the next growth engine–genomics. The Japanese business ($SNE) is entering the sector by setting up a company called P5. It’s...

India’s first New Drug, Synriam, developed by Ranb...

Gurgaon, July 15, 2013: Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359), India’s largest pharmaceutical company, today announced that it has been conferred with the Innovation Excellence Platinum Award at the ASSOCHAM Innovation Awards 2013 in the Science & Technology category for its new anti-malaria drug, SynriamTM. The prestigious award was given by Hon’ble Minister for Science & Technology and...
Page 1 of 1112345...10...Last »